Pooled analysis of p53 mutations in hematological malignancies

• Published in: Human mutation 1998, Vol.12 (1), p.4-18
• Main Authors: Prokocimer, Miron, Unger, Ron, Rennert, Hedy S., Rotter, Varda, Rennert, Gad
• Format: Article
• Language: English
• Subjects: Amino Acid Substitution; Anemia; Carcinogens; etiological factors; Genes, p53; Hematologic Neoplasms - genetics; Hematologic Neoplasms - pathology; hematological malignancies; Hematology; Humans; Leukemia; molecular mechanisms; Mutation; Myelodysplastic syndromes; p53 mutations; Proteins; Tumor Suppressor Protein p53 - genetics; Tumors
• ISSN: 1059-7794; 1098-1004
• DOI: 10.1002/(SICI)1098-1004(1998)12:1<4::AID-HUMU2>3.0.CO;2-G

A computerized database is described that contains information about 507 mutations in the p53 gene of hematologic tumors and corresponding cell lines. Analysis of these mutations indicated the following findings: First, mutational spectrum analysis in these tumors was found to be similar to the pattern found for other solid tumors. However, when the patterns of base substitutions were examined separately according to the types of hematologic malignancies, followed by subgroup analysis, notable differences (in some cases of statistical significance) emerged. Second, mutational pattern analysis indicates that about 48% of base substitutions in hematologic tumors are suspected to be associated with carcinogen exposure. Third, deletions and insertions are localized mainly to exons 5–8 and repeated DNA sequences. However, the unusual profile of variations in frequency within each type of tumor suggests that, in addition to endogenous damage to template DNA, there is the factor of exposure to environmental physical and chemical carcinogens/mutagens. Fourth, p53 protein alterations analysis indicate that most of the changes in the amino acids are “semiconservative,” presumably in order to avoid disrupting the structure of the p53 monomer. Consistent with this notion, structural mutations are more conservative than the binding mutations. Finally, molecular mechanisms that lead to p53 mutations, etiological factors that play a role in their formation, and the pathophysiological significance of consequent p53 protein alterations are discussed. Hum Mutat 12:4–18, 1998. © 1998 Wiley‐Liss, Inc.